SAN FRANCISCO (MarketWatch) ��As concerns over an overheated stock market run high, investor attention this week will shift to the economy, the next Fed chief, and the outlook from tech bellwether Cisco Systems Inc.
The week�� data releases are likely to be muddied by the government�� October shutdown, making it even harder to figure out whether the economic recovery is solid enough for the Federal Reserve to back off its stimulus. Some earnings reports��otably Cisco (CSCO) , Wal-Mart Stores Inc. (WMT) , and a few other retailers��ay help fill in the blanks.
10 Best Tech Stocks To Invest In Right Now: Web.com Group Inc(WWWW)
Web.com Group, Inc. provides Internet services for small- to medium-sized businesses (SMBs) in North America, South America, and the United Kingdom. It provides .com, .net, .co, .org, and .info domains, as well as domain services, including domain name registration, domain name transfers, domain name renewal, domain expiration protection, and domain privacy services; develops and supports a subscription Web service package that includes the tools and functionality necessary for a business to create and maintain online presence, as well as provide tutorials and tools for customers to edit and manage their sites. The company?s primary Do It For Me subscription offering comprise eWorks! XL, which provides domain name registration, initial site design, technical support, Webmail, online Web tools, and Internet scorecard; custom Website design services comprising map and directions pages, external links pages, Website statistics, database applications, password security, and e mail services; and social media and call center services. It also provides various Do-It-Yourself Website building and marketing solutions for SMBs, such as hosting services, Website design tools, email marketing tools, and LogoYes design and brand building tools. In addition, the company offers online marketing services, including search engine optimization, local and national search engine marketing, subscription-based services, budget-based search engine marketing, and click search engine marketing services; lead generation services consisting of Leads by Web.com to contractors, homebuilders, and remodeling professionals; and eCommerce merchant services. Web.com Group, Inc. markets its products and services through outbound and inbound telesales, online channel, affiliate network and private label partners, distribution partners, resellers, and direct sales. The company was incorporated in 1999 and is headquartered in Jacksonville, Florida.
Advisors' Opinion:- [By CRWE]
Web.com Group, Inc. (Nasdaq:WWWW), a leading provider of internet services and online marketing solutions for small- and medium-sized businesses, will report its third quarter results for the fiscal period ended September 30, 2012 after the U.S. financial markets close on October 25, 2012.
10 Best Tech Stocks To Invest In Right Now: Thermo Fisher Scientific Inc(TMO)
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Its Analytical Technologies segment offers analytical instruments to analyze prepared samples, software interpretation tools, laboratory information management systems, and laboratory automation systems; environmental instruments and integrated systems for environmental monitoring, safety, and security applications; and process instruments, integrated systems, and measurement solutions. It also provides diagnostics products used in healthcare laboratories to prepare and analyze patient samples; and biosciences products comprising reagents and consumables used in life science research, drug discovery, and biopharmaceutical production. The company?s Laboratory Products and Services segment offers laboratory equipment, including sample preparation, environment storage and handling equipment, and laboratory workstations; laboratory consumables; research market solutions consisting of chemicals, instruments and apparatus, liquid handling pumps and devices, and capital equipment and consumables; and healthcare market products comprising analytical equipment, diagnostic tools, and reagents and consumables. It also provides workplace and first responder equipment, protective gear, and apparel; and packaging, warehousing, distribution, labeling, pharmaceutical and biospecimen storage, and analytical laboratory services in the area of drug discovery and pharmaceutical clinical trials. The company serves pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial process control settings primarily in the United States, Germany, and the United Kingdom. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Keith Speights]
Thermo Fisher Scientific (NYSE: TMO ) announced today that it will acquire genomics company Life Technologies (NASDAQ: LIFE ) in a $13.6 billion deal. The agreement calls for Thermo Fisher to pay $76 per diluted share, as well as assume around $2.2 billion in Life Technologies' debt.
- [By Rich Duprey]
As part of its plan to pay for the acquisition of Life Technologies (NASDAQ: LIFE ) , life-sciences specialist Thermo Fisher Scientific (NYSE: TMO ) announced yesterday that it was selling 25.7 million shares at $85.50 per share in a public offering of its stock.
- [By John Divine]
Finally, Thermo Fisher Scientific (NYSE: TMO ) , which makes analytical equipment in the health-care sector, lost 2.7% Friday. Though investors can be relieved that today's decline has nothing to do with the IRS, they were understandably not impressed with the company's decision to raise about $2.2 billion through what amounts to the future issuance of more stock. Thermo Fisher will officially issue additional shares when the deal to buy Life Technologies (for $13.6 billion) closes, which is expected to be early 2014. The funds from the offering will be put toward the acquisition.
- [By Monica Gerson]
Thermo Fisher Scientific (NYSE: TMO) is estimated to report its Q3 earnings at $1.28 per share on revenue of $3.18 billion.
General Dynamics (NYSE: GD) is expected to report its Q3 earnings at $1.68 per share on revenue of $7.76 billion.
Top 10 Value Stocks To Invest In Right Now: Concur Technologies Inc.(CNQR)
Concur Technologies, Inc. provides integrated travel and expense management solutions for companies of various industries, sizes, and geographies. It offers the Concur Connect platform, a cloud computing software solution primarily on a subscription basis, which enables customers, partners, suppliers, and third-party developers to connect. The company provides various solutions to streamline the travel procurement, itinerary management, expense management, and invoice management processes. Its solutions include online travel procurement solutions, which automate corporate travel booking and processing; itinerary management solutions that enable individual business travelers and their organizations to manage and share travel itinerary information; and automated expense management solutions, which simplify the expense reporting process. The company also offers other value-added and extended services that leverage its integrated cloud offerings, including expense reimbursemen t; expense report auditing services to streamline the process of managing and substantiating expense receipts; business intelligence that enable customers to use captured data to analyze trends, influence budget decisions, improve forecasting, and monitor for fraudulent activity; and invoice management solutions to automate, simplify, and reduce the costs associated with the process of entering, approving, and managing the payment of vendor invoices. In addition, it provides consulting; and various extended services, such as site administration, audit and compliance services, advanced analytics, and customized integration in connection with its integrated travel and expense management solutions. Concur markets and sells its solutions worldwide through direct sales organizations; and indirect distribution channels, such as strategic resellers and referral partners, as well as through its Website. The company was founded in 1993 and is headquartered in Redmond, Washington.
Advisors' Opinion:- [By Lee Jackson]
The Lazard trading desk said that active traders may want to look at software stocks that still had unusually high short interest. Those included Concur Technologies (NASDAQ: CNQR), Tangoe Inc. (NASDAQ: TNGO), Jive Software (NASDAQ: JIVE), Marketo Inc. (NASDAQ: MKTO), VeriSign Inc. (NASDAQ: VRSN) and VMware Inc. (NYSE: VMW). Stocks with high short interest can explode to the upside if the company gets back on track and short sellers are forced to cover.
- [By Matt Jarzemsky]
Salesforce is up 33% year-to-date. Workday Inc.(WDAY) has rallied 38% and expense-accounting software provider Concur Technologies(CNQR) is up 44%, to name a few.
10 Best Tech Stocks To Invest In Right Now: ANSYS Inc (ANSS)
ANSYS, Inc. (ANSYS) develops and globally markets engineering simulation software and services used by engineers, designers, researchers and students across a range of industries and academia, including aerospace, automotive, manufacturing, electronics, biomedical, energy and defense. The Company distributes its ANSYS suite of simulation technologies through a global network of independent resellers and distributors (collectively, channel partners) and direct sales offices in global locations. The Company�� product portfolio consists of ANSYS Workbench, multiphysics product, structural mechanics, fluid dynamics, explicit dynamics, electromagnetic, system simulation, simulation process and data management, academic, high-performance computing (HPC), geometry interfaces, meshing and Apache design low-power electronic solutions. On August 1, 2011, the Company acquired Apache Design, Inc.
ANSYS Workbench
ANSYS Workbench is the framework upon which the Company�� suite of advanced engineering simulation technologies is built. The ANSYS Workbench platform delivers productivity, enabling Simulation Driven Product Development.
Multiphysics
The Company�� multiphysics product suite allows engineers and designers to create virtual prototypes of their designs operating under multiphysics conditions. ANSYS multiphysics software enables engineers and scientists to simulate the interactions between structural mechanics, heat transfer, fluid flow and electromagnetics all within a single, engineering simulation environment.
Structural Mechanics
The Company�� structural mechanics product suite offers simulation tools for product design. These tools have capabilities that cover a range of analysis types, elements, contacts, materials, equation solvers and coupled physics capabilities all focused towards understanding and solving complex design problems.
Fluid Dynamics
The Company�� fluid dynamics product suit! e offers modeling of fluid flow and other related physical phenomena. Fluid flow analysis capabilities provide all the tools needed to design new fluids equipment and to troubleshoot already existing installations. The fluid dynamics product suite contains general-purpose computational fluid dynamics software and specialized products to address specific industry applications.
Explicit Dynamics
The Company�� explicit dynamics product suite simulates events involving short-duration, large-strain, large-deformation, fracture, complete material failure or structural problems with complex interactions. This product suite is used for simulating physical events that occur in a short period of time and may result in material damage or failure.
Electromagnetics
The Company�� electromagnetics product suite provides field simulation software for designing high-performance electronic and electromechanical products. The software streamlines the design process and predicts performance - all prior to building a prototype - of mobile communication and Internet-access devices, broadband networking components and systems, integrated circuits (IC) and printed circuit boards (PCB), as well as electromechanical systems such as automotive components and power electronics equipment.
System Simulation
The Company delivers the ability to perform complete simulation studies as a system for some of the product designs. This is accomplished through a complete set of physics solutions that are integrated into a multiphysics capabilities set. A collaborative simulation environment provides modeling scalability for evaluating entire systems, including three dimensional (3-D) high-fidelity models, multibody dynamics, circuit reduced-order models, and any combination of these.
Simulation Process and Data Management
ANSYS Engineering Knowledge Manager (ANSYS EKM) is a solution for simulation-based process and data management. ANSY! S EKM pro! vides solutions to all levels of a company, enabling an organization to address the issues associated with simulation data, including backup and archival, traceability and audit trail, process automation and intellectual property protection.
Academic
The Company�� academic product suite provides a portfolio of academic products based on several usage tiers: associate, research and teaching. Each tier includes various noncommercial products that bundle a range of physics and advanced coupled field solver capabilities. The academic product suite provides entry-level tools intended for class demonstrations and hands-on instruction. It provides flexible terms of use and more complex analysis suitable for doctoral and post-doctoral research projects. The Company also provides a product suitable for student use at home.
High-Performance Computing
The Company�� HPC product suite enables insight into product performance. The HPC product suite delivers cross-physics parallel processing capabilities for the full spectrum of the Company�� simulation software by supporting structural, fluids, thermal and electromagnetic simulations in a single HPC solution.
Geometry Interfaces
The Company offers geometry handling solutions for engineering simulation in an integrated environment with direct interfaces to all CAD systems, support of additional readers and translators. It also offers an integrated geometry modeler focused on analysis.
Meshing
Creating a mesh that transforms a physical model into a mathematical model is a critical and foundational step in almost every engineering simulation study. The Company�� meshing technology provides a means to balance these requirements, obtaining the right mesh for each simulation in the most automated way possible.
Apache Design Low-Power Electronic Solutions
The Company�� suite of Apache software delivers power analysis and optimization pl! atforms a! long with integrated methodologies that provide capabilities for managing the power budget, power delivery integrity, and power-induced noise in an electronic design, from initial prototyping to system sign-off. These solutions deliver correlation to silicon measurement, and the capacity to handle an entire electronic system, including IC, package, and PCB.
Advisors' Opinion:- [By Seth Jayson]
Margins matter. The more Ansys (Nasdaq: ANSS ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong Ansys's competitive position could be.
10 Best Tech Stocks To Invest In Right Now: Avago Technologies Limited(AVGO)
Avago Technologies Limited engages in the design, development, and supply of analog semiconductor devices with a focus on III-V based products. Its product portfolio comprises RF amplifiers, RF filters, RF front-end modules, ambient light sensors, light emitting diodes, low noise amplifiers, mm-wave mixers, optical finger navigation products, diodes, fiber optic transceivers, serializer/deserializer ASICs, motion control encoders and subsystems, optocouplers, and optical mouse sensors. The company?s products are used in cellular phones, consumer appliances, data networking and telecommunications equipment, enterprise storage and servers, renewable energy and smart power grid, factory automation, displays, optical mice, printers, voice and data communications, keypad and display backlighting, backlighting control, base stations, storage area networking, in-car infotainment, lighting, motor controls, power supplies, and optical disk drives applications. It markets its produ cts through a network of distributors and its direct sales force worldwide. The company sells approximately 6,500 products to original equipment manufacturers of wireless communications, wired infrastructure, industrial and automotive electronics, and consumer and computing peripherals markets. Avago Technologies Limited was founded in 2005 and is based in Singapore.
Advisors' Opinion:- [By Mani]
Avago Technologies Ltd (NASDAQ:AVGO) should benefit from the robust LTE market in China in the first half of 2014. The company is seeing order strength from low-end, mid, and high-end segments primarily from bands 38-41.
- [By Lee Jackson]
Avago Technologies Ltd. (NASDAQ: AVGO) has entered into a definitive agreement to acquire LSI for $6.6 billion in cash. LSI shareholders will receive a cash payment of $11.15 for each LSI share. The strategic move was aimed to diversify Avago’s existing business line from wired infrastructure, wireless and industrial businesses to the storage chip market to boost revenues in the face of industry consolidation and challenging macroeconomic conditions. Investors are paid a 1.9% dividend. Merrill Lynch has a $60 price target, the same as the consensus target. Avago closed Thursday at $51.44.
- [By Eric Volkman]
In what seems to be turning into a tradition, Avago Technologies (NASDAQ: AVGO ) has again raised its shareholder distribution.
The company on Thursday declared a quarterly dividend of $0.21 per share, to be handed out on June 28 to shareholders of record as of June 17. That amount is $0.02, or 10.5%, higher than Avago Tech's previous distribution of $0.19 per share, which was paid in early April.
- [By Shauna O'Brien]
Canaccord Genuity announced on Monday that it has raised its price target on Avago Technologies Ltd (AVGO).
The firm has maintained a “Buy” rating on AVGO, and has increased the company’s price target from $45 to $53. This price target suggests a 20% upside from the stock’s current price of $42.55.
Analyst Michael Walkly commented: ��eardown analysis of the iPhone 5S and 5C by iFixit suggests Avago has maintained very strong RF dollar content share.”
“We believe these trends are consistent with our long-term thesis that Avago is well positioned to benefit from the rapidly growing demand for FBAR/BAW filters needed to support the growing mix of LTE smartphones.”
“We also believe Avago’s proprietary technologies, strong IP portfolio, and diverse customer base in several growth markets position the company for strong long-term growth trends with industry leading margins,” added the analyst.
Looking ahead, the analyst expects to see 2015 EPS of $3.93 per share. Revenue is expected to be $3.4 billion.
Avago Technologies shares were up 93 cents, or 2.26%, during Monday morning trading. The stock is up 34% YTD.
10 Best Tech Stocks To Invest In Right Now: Tauriga Sciences Inc (TAUG)
Tauriga Sciences, Inc., formerly Immunovative, Inc., incorporated on April 18, 2001, is a development-stage company. The Company along with Constellation Diagnostics, Inc. (Constellation) focuses on establishing a joint venture partnership to develop and commercialize a imaging-based diagnostic technology for use in predictive and preventative oncology.
The Company has rights to commercialize AlloStim and AlloVax. As of March 31, 2013 the Company did not have any revenues.
Advisors' Opinion:- [By Peter Graham]
Small cap health care or personal care stocks Axxess Pharma Inc (OTCMKTS: AXXE), Radiant Creations Group Inc (OTCBB: RCGP) and Tauriga Sciences Inc (OTCMKTS: TAUG) have recently been attracting attention in various investment newsletters or in investor alerts. Some of the attention may have to do with paid promotions that two of these small caps have been the subject of. So how healthy are these three small cap health care or personal care orientated stocks? Here is a checkup:
- [By Peter Graham]
Small cap marijuana stocks IMD Companies Inc (OTCMKTS: ICBU), Tauriga Sciences Inc (OTCMKTS: TAUG), ML Capital Group Inc (OTCBB: MLCG) and Lexaria Corp (OTCMKTS: LXRP) are aiming to give investors a high with their latest news. However, only one of these small cap marijuana stocks appears to be the subject of minor paid promotion or investor relations type of activities. So will investors and traders alike get a high off of these small caps? Here is a quick reality check:
10 Best Tech Stocks To Invest In Right Now: TSR Inc.(TSRI)
TSR, Inc., together with its subsidiaries, provides contract computer programming services to commercial customers, and state and local government agencies in the metropolitan New York area, New England, and the mid-Atlantic region. It offers technical computer personnel to supplement in-house information technology capabilities. The company provides its staffing services in the areas of mainframe and mid-range computer operations, personal computers and client-server support, Internet and e-commerce operations, voice and data communications, and help desk support capabilities. TSR, Inc. was founded in 1969 and is based in Hauppauge, New York.
Advisors' Opinion:- [By Geoff Gannon] ay.
TSRI is typical of the kinds of net-nets you find on this list. The number of net-nets with five straight years of profits is about a dozen stocks. TSR is one of them. It is controlled by the founder. He formed the company 42 years ago. And he still owns 46% of the company today.
Other companies on the list of profitable net-nets also involve one man (or one family) control. These include:
路 Micropac (MPAD)
路 ADDvantage Technologies (AEY)
路 Solitron Devices (SODI)
路 OPT-Sciences (OPST)
Micropac
Micropac is 76% owned by Heinz-Werner Hempel. He�� a German businessman. You can see the German company he founded here. He�� had control of Micropac for a long-time. I don�� have an exact number in front of me. But I would guess it�� been something like 25 years.
ADDvantage
ADDvantage Technologies is controlled by the Chymiak brothers. See the company�� April 4 press release explaining their decision to turn over the CEO position to an outsider. Regardless, the Chymiaks still control 47% of the company. Ken Chymiak is now chairman. And David Chymiak is still a director and now the company�� chief technology officer. Clearly, it�� still their company.
By the way, the name ADDvantage Technologies has nothing to do with the Chymiaks. Today�� AEY really traces its roots to a private company called Tulsat. The Chymiak brothers acquired that company about 27 years ago. So, effectively, when you buy shares of AEY you are buying into a 27-year-old family-controlled company.
That�� pretty typical in the world of net-nets.
Solitron
Solitron Devices is 29% owned by Shevach Saraf. He has been the CEO for 20 years. The post-bankruptcy Solitron has never known another CEO. Before the bankruptcy, Solitron was a much bigger, much different company. So even though we are not talking about the founder here ��and even though 70% of the company�� shares are not held by the CEO
10 Best Tech Stocks To Invest In Right Now: MSCI Inc (MSCI)
MSCI Inc., together with its subsidiaries, provides a suite of performance, risk management, and corporate governance products and services worldwide. The company operates in two segments, Performance and Risk, and Governance. The Performance and Risk segment offers investment decision support tools, including equity indices, real estate indices and benchmarks, portfolio risk and performance analytics, and credit analytics, as well as environmental, social, and governance products. Its products are used in various investment processes, including portfolio construction and rebalancing, performance benchmarking and attribution, risk management and analysis, regulatory and client reporting, index-linked investment product creation, asset allocation, social responsibility assessment, environmental stewardship, investment manager selection, and investment research. The Governance segment provides corporate governance products and services, and specialized financial research and analysis services to institutional investors and corporations. It facilitates the voting of proxies by institutional investors and provides in-depth research and analysis to help inform voting decisions and identify issuer-specific risk; and offers global equity security coverage, and integrated products and services, including proxy voting, policy creation, research, vote recommendations, vote execution, post-vote disclosure, and reporting and analytical tools. This segment also provides class action monitoring and claims filing services to aid institutional investors in the recovery of funds from securities class action settlements. The company offers its products and services under the MSCI, MSCI ESG, Barra, RiskMetrics, ISS, FEA, IPD, and CFRA brands. Its clients include asset owners, institutional and retail asset managers, and financial intermediaries. The company was founded in 1998 and is headquartered in New York, New York.
Advisors' Opinion:- [By Benjamin Shepherd]
The iShares MSCI Emerging Markets Index (NYSE: EEM) seems to have halted its slide.� The index bottomed out year-to-date on February 3, when it was down 11.2 percent. Since then, it has gained 1.5 percent, but bargains in the emerging markets still abound.
As I discussed in �� Plan, Not a Panic��two weeks ago, emerging markets are in much better economic shape today than they were even just a few years ago, much less during the currency crisis that peaked in 1998. Foreign exchange reserves are generally much more robust, budget deficits are narrower if they exist at all and, so far at least, the full-blown currency war that many were predicting last year isn�� likely to breakout.
With rationality finally setting in, this is a terrific time to do a little bargain hunting in the emerging markets.
The most obvious play here is the iShares MSCI Emerging Markets Index itself. Covering China (18.8 percent of assets), South Korea (16 percent), Taiwan (12 percent) and Brazil (10.2 percent) with smaller positions spanning Asia and Europe, the fund is most exposed to any shift in sentiment.
The fund is currently trading at just 10.2 times forward one-year earnings, well below its average of about 18 times over the past two decades. On a price-to-sales basis it is even more attractive valued at just 1.03 times; the last time the index was this cheap on a sales basis was early 2009.
So while there are always dangers in trying to call a bottom to any market move, valuations alone are attractive enough to start pulling bargain hunters back in.
A broadly diversified play on an emerging market turnaround, iShares MSCI Emerging Markets Index is a great buy up to 45, which leaves plenty of room to run back to the average.
For those who can tolerate a bit more risk, you can also drill down and make more country-specific bets.
At this point my favorite would be iShares MSCI South Korea Index Fund (NYSE: EWY).
Sout
10 Best Tech Stocks To Invest In Right Now: StemCells Inc (STEM)
StemCells, Inc. (StemCells), incorporated in August 1988, is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies, and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. The Company�� primary research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The Company has two therapeutic product development programs, including its CNS Program, which is developing applications for HuCNS-SC cells, its human neural stem cell product candidate, and its Liver Program, which is characterizing the Company�� human liver cells as a therapeutic product.
CNS Program
The Company in its CNS Program, is in clinical development with its HuCNS-SC cells for a range of disorders of the central nervous system. The CNS includes the brain, spinal cord and eye. In February 2012, the Company had completed a Phase I clinical trial in Pelizeaus-Merzbacher Disease (PMD), a fatal myelination disorder in the brain.
The Company�� CNS Program is focused on developing clinical applications, in which transplanting HuCNS-SC cells protect or restore organ function of the patient before such function is irreversibly damaged or lost due to disease progression. The Company�� initial target indications are PMD, and more generally, diseases in which deficient myelination plays a central role, such as cerebral palsy or multiple sclerosis; spinal cord injury, disorders in which retinal degeneration plays a central role, such as age-related macular degeneration or retinitis pigmentosa. The Company�� product candidate, HuCNS-SC cells, is a purified and expanded composition of normal human neural stem cells. Its HuCNS-SC cells can be directly transp! lanted.
Liver Program
Liver stem or progenitor cells offer an alternative treatment for liver diseases. A liver cellular therapy or cell-based therapeutic provide or support liver function in patients with liver disease. The Company held a portfolio of issued and allowed patents in the liver field, which cover the isolation and use of both hLEC cells and the isolated subset, as well as the composition of the cells themselves.
The Company�� range of cell culture products, which are sold under the SC Proven brand, includes iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff N2, and NDiff N2B27. Its iSTEM is a serum-free, feeder-free medium that maintains mouse embryonic stem cells in their pluripotent ground state by using selective small molecule inhibitors to block the pathways, which induce differentiation. RHB-A is a defined, serum-free culture medium for the selective culture of human and mouse neural stem cells and their maintenance and expansion as adherent cell populations. RHB-Basal is a defined, serum-free basal medium. When supplemented with specific growth factors, this media is formulated for the propagation and differentiation of adherent neural stem cells. RHB-Basal can also be tailored to specific-cell type requirements by the addition of customer preferred supplements.
The Company�� NDiff N2 is a defined serum-free scell culture supplement for the derivation, maintenance, expansion and/or differentiation of human and mouse embryonic stem (ES) cells and tissue-derived neural stem cells supplement. Its NDiff N2-AF is a serum-free and animal component-free version of NDiff N2. Its NDiff N2B27 is a defined, serum-free medium for the differentiation of mouse embryonic stem cells to neural cell types. NDiff N27-AF is a serum-free and animal component-free version of NDiff N27. Its GS1-R is a serum-free media formulation shown to enable the derivation and long-term maintenance of true, germline competent rat embryonic stem cells without the add! ition of ! cytokines or growth factors. Its GS2-M is a defined, serum- and feeder-free medium for the derivation and long-term maintenance of true, germline competent mouse iPS cells.
The Company also markets a number of antibody reagents for use in cell detection, isolation and characterization. These reagents are also under the SC Proven brand and it includes STEM24, STEM101, STEM121 and STEM123. Its STEM24 is a human antibody that recognizes human CD24, also known as heat stable antigen (HSA), a glycoprotein expressed on the surface of many human cell types, including immature human hematopoietic cells, peripheral blood lymphocytes, erythrocytes and many human carcinomas. Its CD24 is also a marker of human neural differentiation. Its STEM101 is a human-specific mouse antibody that recognizes the Ku80 protein found in human nuclei. Its STEM121 is a human-specific mouse antibody that recognizes a cytoplasmic protein of human cells. Its STEM123 is a human-specific mouse antibody that recognizes human glial fibrillary acidic protein (GFAP).
The Company�� Other products marketed under SC Proven include total cell genomic DNA (gDNA), RNA and protein lysate reagents purified from homogenous stem cell populations for intra-comparative studies, such as Epigenetic fingerprinting, Southern, Western and Northern blots, PCR, RT-PCR and microarrays. This range of purified stem cell line lysates includes mouse embryonic stem (ES) cells propagated in SC Proven 2i inhibitor-based GS2-M media and mouse ES cell-derived and fetal tissue-derived neural stem (NS) cells propagated in SC Proven RHB-A media.
Advisors' Opinion:- [By James E. Brumley]
When an investor thinks of spinal-related stem cell stocks, usually a name like Neuralstem, Inc (NYSEMKT: CUR) or StemCells Inc (NASDAQ: STEM) comes to mind. And well they should. STEM has logged some amazing breakthroughs in the field of spinal cord repair, while CUR has done the same. Not all back problems are spinal cord related though. In fact, most back problems - and therefore the most opportunity - are bone and disc related problems. That's where a young gun like BioRestorative Therapies (OTCBB: BRTX) can step in and make stem cell waves. BRTX has developed an approach to rejuvenate and revive failing spinal discs, potentially ending pain for millions of back-pain sufferers, and circumventing expensive spinal surgeries that are in increasing burden on insurance companies.
10 Best Tech Stocks To Invest In Right Now: Superconductor Technologies Inc.(SCON)
Superconductor Technologies Inc. engages in the development and production of high temperature superconducting (HTS) materials and associated technologies worldwide. The company is leveraging its technologies, including HTS materials and cryogenics, to develop second generation (2G) HTS wire for power applications. Its HTS-based products play a role in emerging power generation, conversion, and distribution applications by enhancing grid reliability and efficiency. The company?s flagship wireless product, SuperLink, combines a specialized filter using patented HTS technology with a proprietary cryogenic cooler and a low-noise amplifier. Its commercial product offerings include SuperLink, a receiver front-end HTS wireless filter system that eliminates out-of-band interference for wireless base stations; AmpLink, a ground-mounted unit for wireless base stations that includes a high-performance amplifier and up to six dual duplexers; and SuperPlex, a multiplexer that provide s low insertion loss and cross-band isolation. The company also grants the U.S. government a royalty-free, non-exclusive, and nontransferable license to use its intellectual property. It sells its products primarily to wireless carriers through direct sales force in the United States, as well as through indirect channels internationally. The company was founded in 1987 and is headquartered in Santa Barbara, California.
Advisors' Opinion:- [By Bryan Murphy]
It's not the kind of thing anybody would have expected to hear, or read, five months ago, but Superconductor Technologies, Inc. (NASDAQ:SCON) is close to becoming one of the market's best bullish short-term bets. Yes, we're talking about the same Superconductor Technologies that plunged from $2.57 to $1.66 in August - hitting new lows in the process - on news that the company was issuing $12 million worth of new stock... right in front of news that SCON booked another significant quarterly loss.� By November, the disaster's final tally was officially recorded - an 82% plunge in the prior quarter's revenue for SCON. As they say though, nothing lasts forever. That includes a malaise that can hold a stock down. Indeed, it's looking like SCON is about to make an explosive move higher.�
- [By Bryan Murphy]
A week and a half ago, not to mention a couple of months ago, I suggested Superconductor Technologies, Inc. (NASDAQ:SCON) was a budding bullish play worthy of your attention. I get the suspicion that while more than a handful of traders read my take, the vast majority of the people who read that commentary weren't as impressed with (SCON) as I was. That's fine. Yet, being a diehard - and perhaps being a glutton for punishment - this is one of those trading ideas I can't let go of, mostly because Superconductor Technologies refuse to give up. Thing is, the stock's given me some new bullish fodder to use since the last look back on January 6th.
- [By Bryan Murphy]
Just for the record, Superconductor Technologies, Inc. (NASDAQ:SCON) isn't over the hump yet. But, given the likelihood that it could get over the hump with little to no fanfare, now's the time to put SCON on your radar.
No comments:
Post a Comment